Wells Fargo Upgrades Achillion Pharmaceuticals (ACHN) to Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. ZETA
9. DAL
10. TMUS

Go back to Wells Fargo Upgrades Achillion Pharmaceuticals (ACHN) to Outperform

Piper Jaffray Upgrades Achillion Pharmaceuticals (ACHN) to Overweight

August 11, 2014 7:02 AM EDT

Piper Jaffray upgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from Neutral to Overweight with a price target of $10.00 (from $5.00). Analyst Edward A. Tenthoff thinks potential suitors could emerge soon.

"Achillion ended 2Q:14 with cash of $131.5 million to advance its emerging HCV pipeline. Achillion... More

Achillion Pharmaceuticals, Inc. (ACHN) Tops Q2 EPS by 2c

August 7, 2014 4:27 PM EDT

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q2 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.

... More